HDAC4 and cardiomyopathy: A large number of important transcription factors or regulators implicated in cardiomyopathy have been identified as bona-fide targets of miR-22, including Purb [12], Hdac4 [13], Ppara [16], Sirt1 [17], and Pgc1a [18].